CARMA Advances Funding for Development of Immunotherapy Program to Treat Metastatic Solid Tumors
News
CARMA Therapeutics has closed an initial financing, co-led by AbbVie Ventures and HealthCap, to build a pipeline of cancer programs using its proprietary chimeric antigen receptor targeting with macrophages (CARMA) ... Read more